Researchers have unlocked a potential revolution in understanding neuropsychiatric disorders.

Harvard researchers have created an antibiotic that can overcome many drug-resistant infections.

Researchers at the Andrew G Myers Research Group at the Harvard University Department of Chemistry and Chemical Biology are engineering synthetic antibiotics that directly target bacteria which cause lower respiratory tract and skin and soft tissue infections.